Cargando…

The Emerging Landscape of Natural Small-molecule Therapeutics for Huntington’s Disease

Huntington’s disease (HD) is a rare and fatal neurodegenerative disorder with no disease-modifying therapeutics. HD is characterized by extensive neuronal loss and is caused by the inherited expansion of the huntingtin (HTT) gene that encodes a toxic mutant HTT (mHTT) protein having expanded polyglu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhat, Shahnawaz Ali, Ahamad, Shakir, Dar, Nawab John, Siddique, Yasir Hassan, Nazir, Aamir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Science Publishers 2023
Materias:	Medicine, Neurology, Pharmacology, Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227909/ https://www.ncbi.nlm.nih.gov/pubmed/36797612 http://dx.doi.org/10.2174/1570159X21666230216104621

Ejemplares similares

Editorial: Investigating the molecular targets and therapeutic potential of Withania somnifera (Ashwagandha) in various pathophysiological conditions
por: Dar, Nawab John, et al.
Publicado: (2023)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Overview, Treatment, and a Case Study
por: Ponnala, Madhusudhan, et al.
Publicado: (2023)

Therapeutic Potential and Pharmaceutical Development of Thymoquinone: A Multitargeted Molecule of Natural Origin
por: Goyal, Sameer N., et al.
Publicado: (2017)

Editorial: Metal-complexed molecules of natural and synthetic origin: Pharmacological advances and therapeutic applications
por: Mohapatra, Ranjan K., et al.
Publicado: (2022)

International Guidelines for the Treatment of Huntington's Disease
por: Bachoud-Lévi, Anne-Catherine, et al.
Publicado: (2019)

Is Ataxia an Underestimated Symptom of Huntington's Disease?
por: Franklin, Gustavo L., et al.
Publicado: (2020)

Inclusion body myositis: Update on the diagnostic and therapeutic landscape
por: Naddaf, Elie
Publicado: (2022)

An ultrasound assisted, ionic liquid-molecular iodine synergy driven efficient green synthesis of pyrrolobenzodiazepine-triazole hybrids as potential anticancer agents
por: Saquib, Mohammad, et al.
Publicado: (2023)

Targeting Tau to Treat Clinical Features of Huntington's Disease
por: Masnata, Maria, et al.
Publicado: (2020)

Mild Cognitive Impairment as an Early Landmark in Huntington's Disease
por: Zhang, Ying, et al.
Publicado: (2021)

Case report: Cerebellar sparing in juvenile Huntington's disease
por: Santos-Lobato, Bruno Lopes, et al.
Publicado: (2023)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Natural compounds targeting mitochondrial dysfunction: emerging therapeutics for target organ damage in hypertension
por: Liao, Xiaolin, et al.
Publicado: (2023)

DNA Methylation Profiles in Whole Blood of Huntington's Disease Patients
por: Zadel, Maja, et al.
Publicado: (2018)

Genetic Counseling in Huntington's Disease: Potential New Challenges on Horizon?
por: Migliore, Simone, et al.
Publicado: (2019)

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review
por: Kinnunen, Kirsi M., et al.
Publicado: (2021)

Neuroinflammation in Huntington’s Disease: A Starring Role for Astrocyte and Microglia
por: Saba, Julieta, et al.
Publicado: (2022)

George Huntington (1850–1916)
por: Owecki, Michał K., et al.
Publicado: (2018)

Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials
por: Kinnunen, Kirsi M., et al.
Publicado: (2021)

Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects
por: Abreu, Daisy, et al.
Publicado: (2021)

Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease
por: Mansoor, Nina M., et al.
Publicado: (2021)

Prevalence of neurocognitive disorder in Huntington’s disease using the Enroll-HD dataset
por: Sierra, Luis A., et al.
Publicado: (2023)

The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions
por: Shams, Shahin, et al.
Publicado: (2021)

JAK/STAT Signaling: Molecular Targets, Therapeutic Opportunities, and Limitations of Targeted Inhibitions in Solid Malignancies
por: Rah, Bilal, et al.
Publicado: (2022)

Michael acceptor molecules in natural products and their mechanism of action
por: Liang, Song-Ting, et al.
Publicado: (2022)

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy
por: Song, Shuailing, et al.
Publicado: (2023)

Gender Differences in Non-sex Linked Disorders: Insights From Huntington's Disease
por: Zielonka, Daniel, et al.
Publicado: (2020)

Juvenile Huntington’s Disease: A Case Report and a Review of Diagnostic Challenges
por: Yu, Su-Yuan, et al.
Publicado: (2023)

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
por: Stout, Julie C, et al.
Publicado: (2012)

Therapeutic Potential of Nitrogen Mustard Based Hybrid Molecules
por: Chen, Yiming, et al.
Publicado: (2018)

Nanoformulations of Ursolic Acid: A Modern Natural Anticancer Molecule
por: Wang, Longyun, et al.
Publicado: (2021)

Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
por: Sathe, Swati, et al.
Publicado: (2021)

Ranking the Predictive Power of Clinical and Biological Features Associated With Disease Progression in Huntington's Disease
por: Ghazaleh, Naghmeh, et al.
Publicado: (2021)

Evaluation of Blood Glial Fibrillary Acidic Protein as a Potential Marker in Huntington's Disease
por: You, Huajing, et al.
Publicado: (2021)

Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
por: Nguyen, Quang Tuan Rémy, et al.
Publicado: (2022)

Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape
por: Li, Shiqi, et al.
Publicado: (2022)

Editorial: Moyamoya disease – natural history and therapeutic challenges
por: Svedung Wettervik, Teodor, et al.
Publicado: (2023)

Editorial: Natural Antimicrobial Peptides: Hope for New Antibiotic Lead Molecules
por: Uddin, Shaikh Jamal, et al.
Publicado: (2021)

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
por: Uddin, Md. Sahab, et al.
Publicado: (2021)

Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction
por: Rahman, Md. Ataur, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8b1sg1iv4r4u70mk51hqs5ioct